Stereotaxis, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on June 25, 2018, reporting events occurring on June 19, 2018. The filing details a material agreement entered into with Biosense Webster, Inc., a key partner in the distribution of the Company's magnetically-navigated catheters.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the execution of a contractual amendment rather than periodic financial performance.
Material Changes and Agreements
- Agreement Amendment: On June 19, 2018, the Company entered into an Eighth Amendment to its Development Alliance and Supply Agreement with Biosense Webster.
- Term Extension: The amendment extends Biosense Webster's worldwide distribution rights for existing magnetically-navigated catheters and associated royalties on a non-exclusive basis through December 31, 2022.
- Exclusivity Clarification: The agreement clarifies that certain exclusivity rights for both parties expired on December 31, 2015.
- Future Development: Development of future versions of compatible CARTO systems will now be subject to mutual agreement between the Company and Biosense Webster.
Outlook, Risks, and Management Commentary
The filing includes standard forward-looking statements regarding future activities and performance, noting that actual results may differ materially due to risks and uncertainties. The Company explicitly states it does not intend to update or revise these forward-looking statements except as required by law. No specific guidance or unusual items were disclosed in this text.
Investor Verification Checklist
- Verify the full text of the Eighth Amendment (Exhibit 10.1) to understand specific royalty terms and conditions.
- Review the June 25, 2018 Press Release (Exhibit 99.1) for additional context on the strategic partnership.
- Confirm the impact of the non-exclusive status on future revenue projections for magnetically-navigated catheters.
- Assess the implications of the mutual agreement requirement for future CARTO system compatibility.